Semaglutide weight loss results linked to diabetes severity

FHS
June 21, 2024
2:31 pm

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

Atai Life Sciences: State of the Company and Projections for the Future | Psychedelic Invest

Atai Life Sciences Q2 financial results were released recently, alongside an update on the company’s pipeline progression. So, we figured it would be a good

August 22, 2023

CommonSpirit’s answer to losing money: get bigger

CommonSpirit Health keeps adding more hospitals — and billions in new debt — even as it bleeds money. Formed through a 2019 merger and headquartered

September 25, 2023

Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) – Biotech Investments

Siegfried AG / Key word(s): Acquisition Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) 02.07.2024 / 06:30 CET/CEST Siegfried (SIX: SFZN) has

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.